The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine

被引:0
|
作者
Xiao-Yong Pu
Zhi-Ping Wang
Yi-Rong Chen
Xing-Huan Wang
Yi-Long Wu
Huai-Peng Wang
机构
[1] Guangdong Provincial People’s Hospital,Department of Urology
[2] Guangdong Provincial People’s Hospital,The Cancer Research Center
[3] Guangdong Provincial People’s Hospital,The Medical Research Center
[4] Lanzou University,Department of of Urology, The Second Hospital
关键词
Bladder cancer; Tumor marker; Survivin; Cytokeratin 20; Mucin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:659 / 665
页数:6
相关论文
共 50 条
  • [1] The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine
    Pu, Xiao-Yong
    Wang, Zhi-Ping
    Chen, Yi-Rong
    Wang, Xing-Huan
    Wu, Yi-Long
    Wang, Huai-Peng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (06) : 659 - 665
  • [2] The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine
    Eissa, Sanaa
    Badr, Soheir
    Abd Elhamid, Shadia
    Helmy, Azza Salah
    Nour, Mohamed
    Esmat, Mohamed
    DISEASE MARKERS, 2013, 34 (01) : 57 - 62
  • [3] Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer
    Golijanin, D
    Shapiro, A
    Pode, D
    JOURNAL OF UROLOGY, 2000, 164 (06): : 1922 - 1925
  • [4] Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer
    Eissa, Sanaa
    Zohny, Samir F.
    Swellam, Menha
    Mahmoud, Manar H.
    El-Zayat, Tarek Mostafa
    Salem, Ahmed M.
    CLINICAL BIOCHEMISTRY, 2008, 41 (16-17) : 1335 - 1341
  • [5] Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs
    Eissa, S
    Kassim, SK
    Labib, RA
    El-Khouly, IM
    Ghaffer, TM
    Sadek, M
    Razek, OA
    El-Ahmady, O
    CANCER, 2005, 103 (07) : 1356 - 1362
  • [6] The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine
    Siracusano, S
    Niccolini, B
    Knez, R
    Tiberio, A
    Benedetti, E
    Bonin, S
    Ciciliato, S
    Pappagallo, GL
    Belgrano, E
    Stanta, G
    EUROPEAN UROLOGY, 2005, 47 (03) : 327 - 333
  • [7] Survivin mRNA expression in urine as a biomarker for bladder cancer
    Nakatani, K.
    Kise, H.
    Noma, K.
    Yasuda, K.
    Sakamoto, Y.
    Matsuo, M.
    Nishioka, J.
    Sugimura, Y.
    Nobori, T.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A116 - A116
  • [8] Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma
    Eissa, S
    Kenawy, G
    Swellam, M
    Abou El-Fadle, A
    El-Aal, AAA
    El-Ahmady, O
    CLINICAL BIOCHEMISTRY, 2004, 37 (09) : 803 - 810
  • [9] Urine detection of survivin and diagnosis of bladder cancer
    Smith, SD
    Wheeler, MA
    Plescia, J
    Colberg, JW
    Weiss, RM
    Altieri, DC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (03): : 324 - 328
  • [10] Detection of bladder cancer by proteomic profiling of voided urine sediments
    Majewski, T
    Fung, E
    Dalmasso, E
    Clarke, C
    Grossman, HB
    Benedict, W
    Johnston, D
    Czerniak, B
    LABORATORY INVESTIGATION, 2003, 83 (01) : 161A - 161A